Anzeige
Mehr »
Login
Samstag, 18.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Spezial Report: NASDAQ-FinTech mit 3.000% Wachstum und 500% Kurs-Chance!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
194 Leser
Artikel bewerten:
(0)

The Biotech Growth Trust Plc - Result of General Meeting

The Biotech Growth Trust Plc - Result of General Meeting

PR Newswire

The Biotech Growth Trust PLC

(the "Company")

Result of General Meeting

27 January 2020

Following a General Meeting of the Company held today, the Board is pleased to announce that the resolution put to Shareholders was passed on a show of hands.

The proxy voting figures are shown below:

ResolutionVotes For%Votes Against%Total Votes CastVotes
Withheld
Special Resolution
  1. THAT the Company be and is hereby generally and unconditionally authorised in accordance with section 701 of the Companies Act 2006 (the "Act") to make one or more market purchases (within the meaning of section 693 (4) of the Act) of ordinary shares of 25 pence each in the capital of the Company either for retention as treasury shares for future reissue, resale, transfer or for cancellation.
15,560,67799.96%5,9720.04%15,566,649831

Notes:

Any proxy votes which are at the discretion of the Chairman have been included in the "for" total. A vote withheld is not a vote in law and is not counted in the votes for or against a resolution.

At the date and time of the General Meeting the total number of Ordinary shares of 25p each in issue and the total number of voting rights was 40,878,780.

The proxy voting figures will shortly also be available on the Company's website at http://www.biotechgt.com/

The full text of the resolution can be found in the Notice of General Meeting contained in the Circular dated 10 January 2020 (the "Circular"), which is available for viewing at the National Storage Mechanism which can be located at http://www.morningstar.co.uk/uk/NSM and on the Company's website, http://www.biotechgt.com/

In accordance with Listing Rule 9.6.2, the full text of the special business resolution passed has been submitted to the National Storage Mechanism and will shortly be available for inspection at: http://www.morningstar.co.uk/uk/nsm. The special business resolution will additionally be filed with Companies House.

Capitalised terms used in this announcement shall, unless the context otherwise requires, bear the meanings given to them in the Circular.

Disclaimer: Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

Legal Entity Identifier: 549300Z41EP32MI2DN29

Enquiries:

Mark Pope

Frostrow Capital LLP

Company Secretary

Telephone: 0203 008 4913

KI-Champions: 3 Top-Werte, die Ihr Portfolio revolutionieren
Fordern Sie jetzt den brandneuen kostenfreien Sonderreport an und erfahren Sie, wie Sie von den enormen Wachstumschancen im Bereich Künstliche Intelligenz profitieren können - 100 % kostenlos.
Hier klicken
© 2020 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.